Applied DNA Sciences, Inc. (APDN)
| Market Cap | 13.55M |
| Revenue (ttm) | 19.27M |
| Net Income (ttm) | -7.50M |
| Shares Out | 12.91M |
| EPS (ttm) | -0.65 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 42,409 |
| Open | 1.09 |
| Previous Close | 1.09 |
| Day's Range | 1.05 - 1.12 |
| 52-Week Range | 0.62 - 7.35 |
| Beta | 0.50 |
| Analysts | Buy |
| Price Target | 4.08 (+288.57%) |
| Earnings Date | Feb 9, 2023 |
About APDN
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain securi... [Read more]
Financial Performance
In 2022, APDN's revenue was $18.17 million, an increase of 101.25% compared to the previous year's $9.03 million. Losses were -$8.38 million, -41.36% less than in 2021.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for APDN stock is "Buy." The 12-month stock price forecast is $4.08, which is an increase of 288.57% from the latest price.
News
What Makes Applied DNA Sciences (APDN) a New Buy Stock
Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Applied DNA Announces New York State Award Valued at Up To $1.5 Million to Support Establishment of cGMP linearDNA™ Production Capacity on Long Island, New York
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced the receipt of an up to $1.5...
Applied DNA Reports First Quarter Fiscal 2023 Financial Results
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidate...
Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction ("PCR")-based technologies, today announced that...
Applied DNA Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of linearDNA™ as a New Class of DNA-Based Vaccines
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced the publication of a peer-reviewed research art...
Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results...
Applied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that it plans to release its fiscal 2022 fourth...
Applied DNA to Establish North America's First Enzymatic (Cell Free) Large-Scale cGMP DNA Manufacturing Capacity in Suffolk County, New York
STONY BROOK, N.Y.
Why Is Applied DNA (APDN) Stock Up 70% Today?
Source: Connect world / Shutterstock.com Applied DNA (NASDAQ: APDN) stock is rocketing higher on Monday after the company announced a massive order for its LinearDNA product. LinearDNA is an enzymati...
Applied DNA Announces Receipt of Largest Single Purchase Order for LinearDNA™ To-Date
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, announced today that it received its largest...
Applied DNA's Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA' or the “Company”), a leader in polymerase chain reaction (PCR”)-based technologies, to...
Applied DNA and the Cornell University College of Veterinary Medicine Announce Research Collaboration to Accelerate Application of LinearDNA™ Platform for Veterinary Health Applications
STONY BROOK, N.Y. & ITHICA, N.Y.--(BUSINESS WIRE)---- $APDN #CUCVM--Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA' or the “Company”), a leader in polymerase chain reaction ("PCR")-based tech...
Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced it will be ...
Applied DNA Launches Monkeypox Testing Service
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, announced today that its wh...
Applied DNA (APDN) Stock Jumps on Monkeypox Test News
Source: Viacheslav Lopatin / Shutterstock.com Applied DNA Sciences (NASDAQ: APDN) stock is rising higher on Friday after the company sent its monkeypox test to the NYSDOH for approval. According to a...
Applied DNA Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of Health
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LDT--Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, announced today that its wholly-o...
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
Monkeypox stocks, our topic for today, have had a mostly mixed performance so far in 2022. It is likely, however, that they could benefit from the similar tailwinds enjoyed by companies, such as Pfize...
Applied DNA Sciences (APDN) Reports Q3 Loss, Tops Revenue Estimates
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 8.33% and 19.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Applied DNA Reports Third Quarter Fiscal 2022 Financial Results
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidate...
Applied DNA Biotherapeutics Subsidiary Reports LinearDNA™ Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles (LNP)
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LNP--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that LineaRx, the Company's majori...
Applied DNA Awarded Extension of Health Services Contract with The City University of New York
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in polymerase chain reaction (“PCR”)-based technologies, today announced that...
Applied DNA Receives Approximately $3.6 Million in Net Proceeds from Warrant Exercise
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in polymerase chain reaction (“PCR”)-based technologies, announced that it ...
Applied DNA to Host Conference Call and Webcast Discussing Fiscal 2022 Third Quarter Results and Corporate Updates
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction ("PCR")-based technologies, t...
Applied DNA Announces Closing of Upsized $12 Million Public Offering
STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #LinearDNA--Applied DNA Sciences, Inc., (NASDAQ: APDN) (the “Company” or “Applied DNA”), a leader in polymerase chain reaction ("PCR")-based technologies, ...
3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency
The White House has declared monkeypox a public health emergency. Within the last two weeks, California, New York and Illinois making the same declaration already, and many other states are sounding t...